{"entity":{"id":"everett-vokes","kind":"person","name":"Everett E. Vokes","aka":[],"tldr":"Head and neck cancer leader who established organ-preserving chemoradiation and led ASCO in 2021-22.","summary":"Everett Vokes is Chair of Medicine at the University of Chicago and served as President of the American Society of Clinical Oncology (ASCO) for 2021 to 2022. A medical oncologist specialising in head and neck and lung cancer, his trials of induction chemotherapy and chemoradiotherapy shaped head and neck cancer treatment and established organ-preserving chemoradiation. His papers include a New England Journal of Medicine review of head and neck cancer and a Journal of Clinical Oncology report on weekly carboplatin and paclitaxel followed by concomitant chemoradiotherapy as curative, organ-preserving therapy for advanced head and neck cancer. His record links to the RTOG 0129 HPV analysis and modern image-guided radiotherapy.","asOf":"2026-09-08","wikipedia":"https://en.wikipedia.org/wiki/Everett_E._Vokes","links":[{"label":"ASCO leadership","url":"https://www.asco.org/about-asco/asco-leadership"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Vokes%20EE%5BAuthor%5D"},{"label":"Google Scholar","url":"https://scholar.google.com/scholar?q=Everett%20E.%20Vokes"}],"tags":[],"related":[],"cancers":["head-and-neck","nsclc"],"sections":[],"technologies":["imrt-igrt"],"targets":[],"drugs":[],"companies":[],"institutions":["asco"],"pathways":[],"terms":[],"trials":["rtog-0129"],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"role":"ASCO President 2021-2022; Chair of Medicine, University of Chicago","institutionId":"asco","specialisms":["Head and neck cancer","Lung cancer","Chemoradiation"],"profiles":[{"label":"ASCO leadership","url":"https://www.asco.org/about-asco/asco-leadership"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Vokes%20EE%5BAuthor%5D"},{"label":"Google Scholar","url":"https://scholar.google.com/scholar?q=Everett%20E.%20Vokes"}],"papers":[{"title":"Head and neck cancer","journal":"New England Journal of Medicine","year":1993,"url":"https://doi.org/10.1056/NEJM199301213280306","doi":"10.1056/NEJM199301213280306"},{"title":"Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: curative and organ-preserving therapy for advanced head and neck cancer","journal":"Journal of Clinical Oncology","year":2003,"url":"https://doi.org/10.1200/JCO.2003.06.006","doi":"10.1200/JCO.2003.06.006"},{"title":"CheckMate 816: three cycles of nivolumab plus chemotherapy before lung cancer surgery","journal":"New England Journal of Medicine","year":2022,"url":"https://doi.org/10.1056/NEJMoa2202170","doi":"10.1056/NEJMoa2202170"}],"orcid":"0000-0002-8645-8068"},"route":"/people/everett-vokes/","neighbours":{"cancer":[{"id":"head-and-neck","kind":"cancer","name":"Head and neck squamous cell carcinoma","route":"/cancers/head-and-neck/"},{"id":"nsclc","kind":"cancer","name":"Non-small-cell lung cancer","route":"/cancers/nsclc/"}],"technology":[{"id":"imrt-igrt","kind":"technology","name":"IMRT / IGRT (modern external beam)","route":"/technologies/imrt-igrt/"}],"institution":[{"id":"asco","kind":"institution","name":"American Society of Clinical Oncology (ASCO)","route":"/institutions/asco/"},{"id":"uchicago-cancer","kind":"institution","name":"University of Chicago Medicine Comprehensive Cancer Center","route":"/institutions/uchicago-cancer/"}],"trial":[{"id":"rtog-0129","kind":"trial","name":"RTOG 0129 (HPV analysis)","route":"/trials/rtog-0129/"}],"paper":[{"id":"paper-checkmate-816-nejm-2022","kind":"paper","name":"CheckMate 816: three cycles of nivolumab plus chemotherapy before lung cancer surgery","route":"/key-papers/paper-checkmate-816-nejm-2022/"}]}}